Detalles de la búsqueda
1.
Enhanced passive safety surveillance of a quadrivalent inactivated split virion influenza vaccine in Finland during the influenza season 2020/21.
BMC Public Health
; 22(1): 1506, 2022 08 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35941631
2.
Enhanced passive safety surveillance of the quadrivalent inactivated split-virion influenza vaccine (IIV4) in Finland during the 2019/20 influenza season.
BMC Public Health
; 21(1): 358, 2021 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33588815
3.
Passive enhanced safety surveillance for Vaxigrip and Intanza 15 µg in the United Kingdom and Finland during the northern hemisphere influenza season 2015/16.
Euro Surveill
; 22(18)2017 May 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28494843
4.
Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study.
Lancet Infect Dis
; 22(5): 636-648, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35090638
5.
Enhanced passive safety surveillance of a trivalent and a quadrivalent influenza vaccine in Denmark and Finland during the 2018/2019 season.
Hum Vaccin Immunother
; 17(4): 1205-1210, 2021 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32966139
6.
Safety of a quadrivalent influenza vaccine in Vietnamese healthy subjects aged 6 months and older.
Hum Vaccin Immunother
; 17(3): 690-693, 2021 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32783746
7.
Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1-2, dose-ranging study.
Lancet Infect Dis
; 21(9): 1257-1270, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33887209
8.
Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in pregnant women: a randomized, observer-blind trial.
Hum Vaccin Immunother
; 16(3): 623-629, 2020 03 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31526225
9.
Immunogenicity and safety of a multi-dose quadrivalent inactivated influenza vaccine in individuals aged 6 months to 17 years: a randomized phase III trial.
Hum Vaccin Immunother
; 16(6): 1380-1384, 2020 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31810418
10.
Enhanced passive safety surveillance of three marketed influenza vaccines in the UK and the Republic of Ireland during the 2017/18 season.
Hum Vaccin Immunother
; 15(9): 2154-2158, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30897026
11.
Report from enhanced safety surveillance of two influenza vaccines (Vaxigrip and Intanza 15 µg) in two European countries during influenza season 2016/17 and comparison with 2015/16 season.
Hum Vaccin Immunother
; 14(2): 378-385, 2018 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29148911
Resultados
1 -
11
de 11
1
Próxima >
>>